Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Welcome to the gala opening of the 30th Stockholm International Film Festival

At the 30th Anniversary, Stockholm International Film Festival proudly presents the Nordic premiere of Noah Baumbach's Marriage Story (2019), Tuesday November 5th at movie theater Skandia in Stockholm. The 1 Km Film winner Julia Thelin also have her world premiere for Lilla Olle (2019). DAY: Tuesday, 5th November 2019 TIME: Doors open at 4:30 pm, photos and interviews can be done at the red-carpet from 5:00 pm to 6:00 pm LOCATION: Movie theater, Skandia, Drottninggatan 82, Stockholm  At 5:45 pm Festival Director Git Scheynius will open this year’s festival together with the

The UK’s Deficit Reached Its Highest Level Since 2016

According to a recent study conducted by Market Inspector , the UK’s import from the EU reached its highest point during the first quarter of 2019 with £93.6 billion. However, at the same time, the UK had a trade deficit of -£3.0 billion with non-EU countries for the first time in the last few years.A Study of The UK’s Imports and Exports Market Inspector based its study of the UK’s trade partners on Trade and Investment Core Statistics Book, published in October 2019 by UK’s Department for International Trade. Interactive maps and graphs were used to

NetEnt unveils new horror slot The Wolf’s Bane ahead of Halloween

Beware the wicked werewolves in The Wolf’s Bane – NetEnt’s dark and sinister new title that stands out from the packNetEnt has launched a spooky new slot, The Wolf’s Bane, where players take on the perspective of a fanged, clawed menace. Released in time for Halloween, The Wolf’s Bane is set in a ravaged 18th century village. The 5-reel, 3-row, 10-payline video slot sees contains wild substitutions, free spins and a bonus pick-and-click feature. The eerie atmosphere is increased by the blood red full moon illuminating the reels, which are haunted by nightmarish nurses, creepy

Repo rate unchanged at –0.25 per cent

After several years of strong economic activity and inflation close to the target of 2 per cent, the Swedish economy is slowing down and the economic conditions are becoming more normal. In recent months, inflation has indeed fallen back, but this was expected and overall, the inflation prospects for the next year are unchanged. In line with the forecast from September, the Executive Board has therefore decided to leave the repo rate unchanged at –0.25 per cent. As before, the forecast indicates that the interest rate will most probably be raised in December to zero percent. Uncertainty over

IPKO trials Teleste’s latest Remote PHY technology together with Cisco’s CCAP core

Turku, Finland - 24 October 2019 - Distributed access networks are taking a step forward in Kosovo, where the leading telecommunications operator IPKO Telecommunications LLC (IPKO) trials Teleste’s latest Remote PHY technology together with a CCAP core from Cisco. In the trial, the implementation of a Remote PHY based distributed access network is evaluated for the delivery of even greater broadband speeds for the customers of IPKO that is considered as one of the fastest growing telecommunications companies in Europe. “As a key element of distributed access architecture, Remote PHY

UPM’s President and CEO Jussi Pesonen to continue in his current position until further notice

UPM-Kymmene Corporation    Stock Exchange Release (Changes board/management/auditors)  24 October 2019 at 10:30 EET UPM’s President and CEO Jussi Pesonen to continue in his current position until further notice At the request of UPM-Kymmene Corporation’s Board of Directors Jussi Pesonen will continue as President and CEO until further notice. According to his executive contract he was entitled to retire in November 2020 at the age of 60. Jussi Pesonen has informed the Board that he is not available for re-election to UPM’s Board of Directors in the annual general meeting of 2020.

Oboya carries out relocation of operations and warehouses, which entails an annual cost saving of SEK 5.0 million

Oboya Horticulture Industries AB ("Oboya" or "The Company"), through wholly-owned subsidiaries in Sweden and Denmark, carries out relocation of operations and warehouses. The change entails an annual cost saving of MSEK 5.0 with full effect from the first quarter of 2020. The relocation is part of previously communicated profitability improvement and the Company's strategic plan to achieve a net margin of 5-7 percent. Oboya has previously announced that the focus for the coming years is to achieve sustainable profitability. In order to achieve the stated target of a net margin of 5–7

Dates for SSAB’s financial reports in 2020

Dates for SSAB’s financial reports in 2020 and the AGM January 28, 2020              Financial statement release (year-end report) for 2019 April 27, 2020                    Q1 – Interim report for January-March 2020 July 21, 2020                     Q2 –Interim report for January-June 2020 October 22, 2020              Q3 – Interim report for January-September 2020 Reports are published at 7.30am CET/CEST on the release date unless otherwise announced. The Annual Report 2019 will be published in week 12. The Annual General Meting 2020 will be held in Stockholm

Agenda for Enea Capital Markets Day 2019

Stockholm, Sweden, October 23, 2019, Enea® (Nasdaq Stockholm: ENEA) Enea is arranging a capital markets day on November 5, 2019. The event takes place at the IVA Conference Center at Grev Turegatan 16 in Stockholm and is intended for investors, analysts, and media. It will start at 1:00 PM and during the afternoon Jan Häglund, President and Chief Executive Officer of Enea, and members of Enea’s Executive Management Team, will provide insight into the company’s offering, strategy, and financial performance. The agenda looks as follows:1:00 PM  Business and Strategy Update- Jan

Invitation to John Mattson’s presentation of the interim report for January–September 2019 on 7 November at 10:00 am (CET)

On 7 November at 8:00 am (CET), John Mattson AB (publ) will publish its interim report for January–September 2019. Accordingly, investors, asset managers, financial analysts and the press are invited to a presentation where CEO Siv Malmgren and CFO Maria Sidén will present and comment on the second quarter and the interim report. The interim report will be available for download at https://corporate.johnmattson.se/en/financial-reports/ The presentation starts at 10:00 am (CET) and will be held in Swedish. Link to the presentation: https://tv.streamfabriken.com/johnmattson-q3-2019

Oblique Therapeutics will be presenting at the Inaugural RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020

Gothenburg, Sweden, October 24, 2019 – Oblique Therapeutics AB announces that Sreesha P Srinivasa is on the list of invited speakers who will be presenting at the RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020.Sreesha P Srinivasa, Senior Vice President at Oblique Therapeutics will be presenting the company’s KRAS antibody program, targeting KRAS driven malignancies such as lung and colon cancer, at the summit early next year. The summit unites experts in the RAS field; big pharma, biotech and academia. They are all trying to develop medicines targeting RAS, a

Rabbalshede Kraft and Modvion enters new collaboration

Rabbalshede Kraft, a leading wind project developer in the Nordics, has signed a letter of intent regarding 10 of Modvion’s modular wind power towers made of laminated wood, for their planned wind farm in Fägremo, Töreboda municipality. Given a successful collaboration, Modvion could potentially deliver towers to Rabbbalshede kraft to an estimated value of SEK 500–900 million over the 5 years to follow.“In the Fägremo park we have applied to build turbines with a total height of 240 m. By using modular Modvion towers in wood, we avoid logistical difficulties, reduce weight and approach

Austin Engineering named Swedish Steel Prize 2019 finalist

For developing a revolutionary, two-piece mining excavator bucket that clearly opens up for further bucket design innovations, Austin Engineering has been nominated for the Swedish Steel Prize 2019. The Swedish Steel Prize, which celebrates its 20th anniversary this year, aims to recognize the good engineering, cooperation and steel innovations that lead to a better and more sustainable world. Austin Engineering, from Australia is one of the four finalists for this year’s prize, which will be awarded during a ceremony in Stockholm, Sweden on November 14. The award ceremony is part

Teleste: Interim Report Q3 2019 will be published on October 31st - Invitation to press briefing

TELESTE CORPORATION       INVESTOR NEWS        24.10.2019    AT 10:00 EET TELESTE: INTERIM REPORT Q3 2019 WILL BE PUBLISHED ON OCTOBER 31st - INVITATION TO PRESS BRIEFING Teleste will publish its Interim Report 1 January – 30 September 2019 as a stock exchange release on October 31st approx. at 08:30 a.m. EET. A briefing for investors, media and analysts and will be held the same day in Helsinki hosted by CEO, Mr. Jukka Rinnevaara. Teleste's CFO, Mr. Juha Hyytiäinen will also be present in the briefing.  PRESS BRIEFING (held in Finnish):Date: Thursday, October 31st 2019

Super dynamic tension springs in next generation’s trampoline

In order to provide the best possible trampoline experience, tension springs  with ultimate properties are required. North Trampoline has, assisted by Lesjöfors, developed a premium product with the exact firmness and a long lifespan, that professional jumpers call "world class".In North Trampoline’s development process of the Performer Revolution  for jumpers with higher demands on performance, quality and safety, the existing spring solution needed to be refined and improved. Therefore, in 2018

UPM Interim Report Q3/2019: UPM reports good performance and strong financial position – Uruguay decision drives significant future earnings growth

UPM-Kymmene Corporation                   Interim Report               24 October 2019 at 09:55 EET UPM Interim Report Q3/2019: UPM reports good performance and strong financial position – Uruguay decision drives significant future earnings growth Q3 2019 highlights · Sales decreased by 6% to EUR 2,493 million (2,650 million in Q3 2018) · Comparable EBIT decreased by 19% to EUR 342 million (420 million) · Sales prices decreased in pulp, outweighing the impact of lower variable costs in all business areas · UPM announced the transformative investment in Uruguay for

Vator Securities: AlzeCure Pharma - A win for the amyloid hypothesis is a win for AlzeCure

Biogen’s progress with its Alzheimer’s disease drug (aducanumab) gives support for the amyloid hypothesis and significantly strengthens AlzeCure’s case. The company’s Alzstatin-program focuses on disease-modifying therapies for early Alzheimer’s disease by reducing the production of amyloid beta. It also offers several advantages over some of the more advanced peers such as BioArctic’s BAN2401 and Biogen’s aducanumab. We expect that future progress and generation of satisfactory data will drive the stock price and trigger an elevated company valuation. Läs mer och ladda ned analysen:

Follicum receives Eurostars grant to develop the company's first-in-class treatment of diabetes

Follicum today announces that the company’s application for a Eurostars grant comprising the development of a first-in-class treatment for diabetes has been approved. Follicum is the coordinator of the project. Other partners include Lund University, Bioassay Labor für biologische Analytik GmbH and Deutsche Diabetes-Forschungsgesellschaft (DDZ).The grant comprising just under EUR 0.7 M commences December 1, 2019 and provides additional resources for the Company's development of a peptide-based treatment of diabetes. Follicum, together with other partners in the consortium, will study

Interim Report, January - September 2019

Period July 1 – September 30, 2019 · Net sales of SEK 92.4 m (SEK 95.6 m) · Software revenues of SEK 66.1 m (SEK 64.8 m) · Recurring revenues of SEK 61.4 m (SEK 56.3 m) which corresponds to 66 % (59 %) of net sales. · EBITDA SEK 24.3 m; 26.3 % (SEK 25.6 m; 26.8 %) · EBITDA-adj. SEK 14.5 m; 15.7 % (SEK 16.9 m; 17.7 %) · EBIT SEK 11.2 m; 12.1 % (SEK 13.9 m; 14.5 %) · Net profit SEK 8.3 m; 8.9 % (SEK 10.1 m; 10.6 %) · EPS before dilution SEK 0.16 (SEK 0.19) · Cash flow from operating activities SEK 21.5 m (SEK 19.9 m) Period January 1 – September 30, 2019 ·

Inhalation Sciences technology spotlighted by researchers at 4 major industry events

From Austria to Sweden to California to the UK: October has been an intensive month for Inhalation Sciences' flagship aerosol generator PreciseInhale. It has been spotlighted by senior ISAB clients such as Fraunhofer ITEM at four global industry events. “Customers of this calibre sharing the findings they’re achieving really underlines the strategic value we deliver” says ISAB CEO Manoush Masarrat.PreciseInhale has been presented at four different inhalation events in October, each time by clients showcasing specific benefits and findings they got from the system. “The range of events

Archer Limited: Announcement of third quarter 2019 earnings release date and conference call information

Hamilton, Bermuda (October 24, 2019) Archer Limited's third quarter 2019 earnings are scheduled to be released on November 6, 2019 before the start of trading on Oslo Stock Exchange.  In connection with the earnings release, a conference call will be held at 8:00am London time, 9:00am Oslo time on November 6, 2019. To listen to the conference call, the following options are available: A. Webcast To register for the webcast please go to https://archer.eventcdn.net/2019q3/   B. Conference call To access the call, which is open to the public, please contact the conference

Breakthrough: ExpreS2ion launches first unique cell line for enhanced efficacy of vaccines and immunotherapy

After several years of research and development, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces the launch of a new tailormade S2 cell line, HighMan-S2™. This is the first member of ExpreS2ion’s new functionally modified S2 product line, GlycoX-S2™, which utilises and expands the advantages of the ExpreS2 platform.For several years, ExpreS[2]ion has been working on the development of adding functional modifications to its powerful ExpreS[2] platform. This makes the introduction of the new HighMan-S2™ cell line an important

AR Packaging to launch fibre-based cutlery in cooperation with Bionatic

AR Packaging aims to meet the increasing need for replacement of plastic-based cutlery and has teamed up with the food service distributor Bionatic to launch a fibre-based cutlery range.Since the European Single-Use Plastics Directive (SUP) was introduced, both consumers and member states have started to reconsider many plastic packaging items on the market. By 2021, plastic cutlery will be banned in the EU. While targeting some of the issues related to unrecyclable items and potential littering, the demand for eating on-the-go will remain. There is therefore a great need for a new

Change in Eltel Management Team – CFO Petter Traaholt to leave Eltel

Petter Traaholt, Chief Financial Officer (CFO) of Eltel, will leave the company to assume the position as CFO at V.Group, the leading ship management and marine services provider based in London. A search process for his successor will start immediately.Petter Traaholt will continue in his position until end of February 2020. – During his time with the company, Petter has, together with the management team, been instrumental in the ongoing transformation of the business. Over the past years, we have de-risked the company, restructured the business into a country-based organization, re-

There are no items matching the current filter
There are no more items matching the current filter
Back to top